Chronic Kidney Disease (CKD) Drugs Market, Global Outlook and Forecast 2023-2029

Publisher Name :
Date: 31-Jan-2023
No. of pages: 74

Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.

This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease (CKD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease (CKD) Drugs. This report contains market size and forecasts of Chronic Kidney Disease (CKD) Drugs in global, including the following market information:

Global Chronic Kidney Disease (CKD) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Chronic Kidney Disease (CKD) Drugs Market Sales, 2018-2023, 2024-2029, (K Units)

Global top five Chronic Kidney Disease (CKD) Drugs companies in 2022 (%)

The global Chronic Kidney Disease (CKD) Drugs market was valued at US$ 14390 million in 2022 and is projected to reach US$ 16070 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Calcium channel blockers surfaced as the key drug class

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Kidney Disease (CKD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chronic Kidney Disease (CKD) Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Chronic Kidney Disease (CKD) Drugs Market Segment Percentages, by Type, 2022 (%)

- ACE Inhibitors

- Angiotensin-II Receptor Blockers

- Calcium Channel Blockers

- Beta Blockers: BREVIBLOC, Bystolic

- Others

Global Chronic Kidney Disease (CKD) Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Chronic Kidney Disease (CKD) Drugs Market Segment Percentages, by Application, 2022 (%)

- Hospitals

- Specialty Clinics

Global Chronic Kidney Disease (CKD) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Chronic Kidney Disease (CKD) Drugs Market Segment Percentages, By Region and Country, 2022 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chronic Kidney Disease (CKD) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Chronic Kidney Disease (CKD) Drugs revenues share in global market, 2022 (%)

Key companies Chronic Kidney Disease (CKD) Drugs sales in global market, 2018-2023 (Estimated), (K Units)

Key companies Chronic Kidney Disease (CKD) Drugs sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Pfizer, Inc.

- Amgen

- Roche

- GlaxoSmithKline (GSK)

- Allergan

- AbbVie

- Kissei Pharmaceutical Co., Ltd.

Outline of Major Chapters:

Chapter 1: Introduces the definition of Chronic Kidney Disease (CKD) Drugs, market overview.

Chapter 2: Global Chronic Kidney Disease (CKD) Drugs market size in revenue and volume.

Chapter 3: Detailed analysis of Chronic Kidney Disease (CKD) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chronic Kidney Disease (CKD) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Chronic Kidney Disease (CKD) Drugs capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Chronic Kidney Disease (CKD) Drugs Market, Global Outlook and Forecast 2023-2029

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Chronic Kidney Disease (CKD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Kidney Disease (CKD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Kidney Disease (CKD) Drugs Overall Market Size
2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size: 2022 VS 2029
2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chronic Kidney Disease (CKD) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Chronic Kidney Disease (CKD) Drugs Players in Global Market
3.2 Top Global Chronic Kidney Disease (CKD) Drugs Companies Ranked by Revenue
3.3 Global Chronic Kidney Disease (CKD) Drugs Revenue by Companies
3.4 Global Chronic Kidney Disease (CKD) Drugs Sales by Companies
3.5 Global Chronic Kidney Disease (CKD) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chronic Kidney Disease (CKD) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chronic Kidney Disease (CKD) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Kidney Disease (CKD) Drugs Market Size Markets, 2022 & 2029
4.1.2 ACE Inhibitors
4.1.3 Angiotensin-II Receptor Blockers
4.1.4 Calcium Channel Blockers
4.1.5 Beta Blockers: BREVIBLOC, Bystolic
4.1.6 Others
4.2 By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue & Forecasts
4.2.1 By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Chronic Kidney Disease (CKD) Drugs Sales & Forecasts
4.3.1 By Type - Global Chronic Kidney Disease (CKD) Drugs Sales, 2018-2023
4.3.2 By Type - Global Chronic Kidney Disease (CKD) Drugs Sales, 2024-2029
4.3.3 By Type - Global Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Chronic Kidney Disease (CKD) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Kidney Disease (CKD) Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue & Forecasts
5.2.1 By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Chronic Kidney Disease (CKD) Drugs Sales & Forecasts
5.3.1 By Application - Global Chronic Kidney Disease (CKD) Drugs Sales, 2018-2023
5.3.2 By Application - Global Chronic Kidney Disease (CKD) Drugs Sales, 2024-2029
5.3.3 By Application - Global Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Chronic Kidney Disease (CKD) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Chronic Kidney Disease (CKD) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue & Forecasts
6.2.1 By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Chronic Kidney Disease (CKD) Drugs Sales & Forecasts
6.3.1 By Region - Global Chronic Kidney Disease (CKD) Drugs Sales, 2018-2023
6.3.2 By Region - Global Chronic Kidney Disease (CKD) Drugs Sales, 2024-2029
6.3.3 By Region - Global Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2029
6.4.2 By Country - North America Chronic Kidney Disease (CKD) Drugs Sales, 2018-2029
6.4.3 US Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.4.4 Canada Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.4.5 Mexico Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Chronic Kidney Disease (CKD) Drugs Sales, 2018-2029
6.5.3 Germany Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.5.4 France Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.5.5 U.K. Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.5.6 Italy Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.5.7 Russia Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.5.9 Benelux Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Chronic Kidney Disease (CKD) Drugs Sales, 2018-2029
6.6.3 China Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.6.4 Japan Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.6.5 South Korea Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.6.7 India Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2029
6.7.2 By Country - South America Chronic Kidney Disease (CKD) Drugs Sales, 2018-2029
6.7.3 Brazil Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.7.4 Argentina Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales, 2018-2029
6.8.3 Turkey Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.8.4 Israel Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
6.8.6 UAE Chronic Kidney Disease (CKD) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Company Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Major Product Offerings
7.1.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer, Inc. Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Major Product Offerings
7.2.4 Amgen Chronic Kidney Disease (CKD) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Chronic Kidney Disease (CKD) Drugs Major Product Offerings
7.3.4 Roche Chronic Kidney Disease (CKD) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 GlaxoSmithKline (GSK)
7.4.1 GlaxoSmithKline (GSK) Company Summary
7.4.2 GlaxoSmithKline (GSK) Business Overview
7.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Major Product Offerings
7.4.4 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline (GSK) Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Major Product Offerings
7.5.4 Allergan Chronic Kidney Disease (CKD) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Major Product Offerings
7.6.4 AbbVie Chronic Kidney Disease (CKD) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Kissei Pharmaceutical Co., Ltd.
7.7.1 Kissei Pharmaceutical Co., Ltd. Company Summary
7.7.2 Kissei Pharmaceutical Co., Ltd. Business Overview
7.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Major Product Offerings
7.7.4 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Kissei Pharmaceutical Co., Ltd. Key News & Latest Developments
8 Global Chronic Kidney Disease (CKD) Drugs Production Capacity, Analysis
8.1 Global Chronic Kidney Disease (CKD) Drugs Production Capacity, 2018-2029
8.2 Chronic Kidney Disease (CKD) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Kidney Disease (CKD) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Kidney Disease (CKD) Drugs Supply Chain Analysis
10.1 Chronic Kidney Disease (CKD) Drugs Industry Value Chain
10.2 Chronic Kidney Disease (CKD) Drugs Upstream Market
10.3 Chronic Kidney Disease (CKD) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Kidney Disease (CKD) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Chronic Kidney Disease (CKD) Drugs in Global Market
Table 2. Top Chronic Kidney Disease (CKD) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chronic Kidney Disease (CKD) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Chronic Kidney Disease (CKD) Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type
Table 9. List of Global Tier 1 Chronic Kidney Disease (CKD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), 2024-2029
Table 16. By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), 2024-2029
Table 21. By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer, Inc. Company Summary
Table 47. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product Offerings
Table 48. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer, Inc. Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Chronic Kidney Disease (CKD) Drugs Product Offerings
Table 52. Amgen Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Chronic Kidney Disease (CKD) Drugs Product Offerings
Table 56. Roche Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. GlaxoSmithKline (GSK) Company Summary
Table 59. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product Offerings
Table 60. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. GlaxoSmithKline (GSK) Key News & Latest Developments
Table 62. Allergan Company Summary
Table 63. Allergan Chronic Kidney Disease (CKD) Drugs Product Offerings
Table 64. Allergan Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Allergan Key News & Latest Developments
Table 66. AbbVie Company Summary
Table 67. AbbVie Chronic Kidney Disease (CKD) Drugs Product Offerings
Table 68. AbbVie Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. AbbVie Key News & Latest Developments
Table 70. Kissei Pharmaceutical Co., Ltd. Company Summary
Table 71. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product Offerings
Table 72. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Kissei Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 74. Chronic Kidney Disease (CKD) Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Chronic Kidney Disease (CKD) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Chronic Kidney Disease (CKD) Drugs Production by Region, 2018-2023 (K Units)
Table 77. Global Chronic Kidney Disease (CKD) Drugs Production by Region, 2024-2029 (K Units)
Table 78. Chronic Kidney Disease (CKD) Drugs Market Opportunities & Trends in Global Market
Table 79. Chronic Kidney Disease (CKD) Drugs Market Drivers in Global Market
Table 80. Chronic Kidney Disease (CKD) Drugs Market Restraints in Global Market
Table 81. Chronic Kidney Disease (CKD) Drugs Raw Materials
Table 82. Chronic Kidney Disease (CKD) Drugs Raw Materials Suppliers in Global Market
Table 83. Typical Chronic Kidney Disease (CKD) Drugs Downstream
Table 84. Chronic Kidney Disease (CKD) Drugs Downstream Clients in Global Market
Table 85. Chronic Kidney Disease (CKD) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Kidney Disease (CKD) Drugs Segment by Type in 2022
Figure 2. Chronic Kidney Disease (CKD) Drugs Segment by Application in 2022
Figure 3. Global Chronic Kidney Disease (CKD) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Kidney Disease (CKD) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chronic Kidney Disease (CKD) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Chronic Kidney Disease (CKD) Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Kidney Disease (CKD) Drugs Revenue in 2022
Figure 9. By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Chronic Kidney Disease (CKD) Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Chronic Kidney Disease (CKD) Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 23. US Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 28. Germany Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 37. China Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Chronic Kidney Disease (CKD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Chronic Kidney Disease (CKD) Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Chronic Kidney Disease (CKD) Drugs by Region, 2022 VS 2029
Figure 54. Chronic Kidney Disease (CKD) Drugs Industry Value Chain
Figure 55. Marketing Channels
  • Global Hemodialysis Powder Solution Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Hemodialysis Powder Solution market was valued at US$ 392.9 million in 2023 and is anticipated to reach US$ 594.8 million by 2030, witnessing a CAGR of 6.6% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in re......
  • Global Hemodialysis Concentrates Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Hemodialysis Concentrates market size was valued at US$ 2408.5 million in 2023. With growing demand in downstream market, the Hemodialysis Concentrates is forecast to a readjusted size of US$ 3027 million by 2030 with a CAGR of 3.3% during review period. The research report highlights the growth potential of the global Hemodialysis Concentrates market. Hemodialysis Concentrates are expected to show stable growth in the future......
  • Global Hemodialysis Concentrates Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 159
    According to our (Global Info Research) latest study, the global Hemodialysis Concentrates market size was valued at USD 2533.3 million in 2023 and is forecast to a readjusted size of USD 3128.8 million by 2030 with a CAGR of 3.1% during review period. Hemodialysis concentrates including: Acid concentrates A-concentrate Acidified concentrated mixture of salts that, when diluted with dialysis water and bicarbonate concentrate, yields dialysis fluid for use in dialysis......
  • Hemodialysis Powder Solution - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Hemodialysis Powder Solution market size is expected to reach US$ 594.8 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Hemodialysis Powder Solution in various end use industries. The expanding demands from the Public Hospital, Private Clinic, Nursing Home and Personal Care, are propelling Hemodialysis Powder Solution market. Hemodialysis Concentrates, one of the segments analysed in this report, is projected......
  • Global Peritoneal Dialysis Solution Market Research Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 139
    During peritoneal dialysis, a cleansing fluid (dialysate) is circulated through a tube (catheter) inside part of your abdominal cavity (peritoneal cavity). The dialysate absorbs waste products from blood vessels in your abdominal lining (peritoneum) and then is drawn back out of your body and discarded. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million U......
  • Global Peritoneal Dialysis Solution Professional Survey Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 100
    During peritoneal dialysis, a cleansing fluid (dialysate) is circulated through a tube (catheter) inside part of your abdominal cavity (peritoneal cavity). The dialysate absorbs waste products from blood vessels in your abdominal lining (peritoneum) and then is drawn back out of your body and discarded. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million U......
  • Global Hemodialysis Concentrates Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Hemodialysis Concentrates market: According to our latest research, the global Hemodialysis Concentrates market looks promising in the next 5 years. As of 2022, the global Hemodialysis Concentrates market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hemodialysis, also spelled haemodialysis, commonly called kidney dialysis or simply dialysis, is a process of purify......
  • Global Hemodialysis Powder Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Hemodialysis Powder Solution market: According to our latest research, the global Hemodialysis Powder Solution market looks promising in the next 5 years. As of 2022, the global Hemodialysis Powder Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • Global Hemodialysis Powder Solution Market Research Report 2023
    Published: 12-Oct-2023        Price: US 2900 Onwards        Pages: 94
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hemodialysis Powder Solution market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Baxter - Rockwell Medical - Fresenius - B. Braun - Renacon Pharma - Chief Medical Supplies - Farmasol - Weigao - Tia......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs